Brissette L, Roach P D, Noël S P
J Biol Chem. 1986 Sep 5;261(25):11631-8.
Rat intermediate density lipoproteins (IDL) bind specifically to high and low affinity binding sites on rat liver membranes. In a recent paper (Brissette, L., and Noël, S.-P. (1986) J. Biol. Chem. 261, 6847-6852), we have demonstrated that human low density lipoproteins and high density lipoproteins-3 can totally prevent the specific binding of rat IDL to the low affinity binding sites. The aim of the present studies was to determine the effects of apoA-I, apoC, and apoE, reconstituted into liposomes, on the binding of rat iodinated IDL to rat liver membranes. We found that a 50-, 100-, or 300-fold excess of liposome-reconstituted apoE, apoC, or apoA-I, respectively, abolished the specific binding of IDL to the low affinity binding sites. Only apoE liposomes had an effect on the high affinity component; at a 100-fold excess no specific binding of IDL could be detected. Liposomes by themselves or associated with erythrocyte membrane proteins had virtually no effect on the binding of IDL. Taken together our results suggest that apoE is the only ligand that can compete efficiently for the sites that bind rat IDL with a high affinity. These sites may be the expression of both the remnant and the LDL receptors. The binding to the low affinity component probably represents weak interactions between IDL and "unspecified-lipoprotein binding sites," which can be entirely masked by human low density lipoproteins, high density lipoproteins-3, or liposome-reconstituted apoA-I, apoE, or apoC at appropriate concentrations.
大鼠中间密度脂蛋白(IDL)能特异性结合大鼠肝细胞膜上的高亲和力和低亲和力结合位点。在最近一篇论文(布里塞特,L.,和诺埃尔,S.-P.(1986年)《生物化学杂志》261卷,6847 - 6852页)中,我们已经证明人低密度脂蛋白和高密度脂蛋白-3能完全阻止大鼠IDL与低亲和力结合位点的特异性结合。本研究的目的是确定重构于脂质体中的载脂蛋白A-I、载脂蛋白C和载脂蛋白E对大鼠碘化IDL与大鼠肝细胞膜结合的影响。我们发现,脂质体重构的载脂蛋白E、载脂蛋白C或载脂蛋白A-I分别过量50倍、100倍或300倍时,可消除IDL与低亲和力结合位点的特异性结合。只有载脂蛋白E脂质体对高亲和力成分有影响;过量100倍时,检测不到IDL的特异性结合。脂质体本身或与红细胞膜蛋白结合时,对IDL的结合几乎没有影响。综合我们的结果表明,载脂蛋白E是唯一能有效竞争与大鼠IDL高亲和力结合位点的配体。这些位点可能是残余受体和低密度脂蛋白受体的共同表达。与低亲和力成分的结合可能代表IDL与“未明确的脂蛋白结合位点”之间的弱相互作用,在适当浓度下,人低密度脂蛋白、高密度脂蛋白-3或脂质体重构的载脂蛋白A-I、载脂蛋白E或载脂蛋白C可完全掩盖这些位点。